comparemela.com
Home
Live Updates
Hepagene Therapeutics Announces FDA Clearance of Investigati
Hepagene Therapeutics Announces FDA Clearance of Investigati
Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist
/PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical-stage biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has...
Related Keywords
China ,
Nanjing ,
Jiangsu ,
Michaelx Xu ,
,
Drug Administration ,
Prnewswire Hepagene Therapeutics Inc ,
Hepagene Therapeutics Inc ,
Investigational New Drug ,
Thyroid Hormone Receptor ,
Hepagene Therapeutics ,
Nc ,